Biblio

Grimm DR, Beswick DM, Maoz SL, Wang EW, Choby GW, Kuan EC, Chan EP, Adappa ND, Geltzeiler M, Getz AE et al..  2024.  SNOT-22 subdomain outcomes following treatment for sinonasal malignancy: A prospective, multicenter study.. Int Forum Allergy Rhinol.

Maoz SL, Golzar A, Choby G, Hwang PH, Wang EW, Kuan EC, Adappa ND, Geltzeiler M, Getz AE, Humphreys IM et al..  2024.  University of Washington Quality of Life subdomain outcomes after treatment of sinonasal malignancy: A prospective, multicenter study.. Int Forum Allergy Rhinol.

Roland LT, Humphreys IM, Le CH, Babik JM, Bailey CE, Ediriwickrema LS, Fung M, Lieberman JA, Magliocca KR, Nam HH et al..  2023.  Diagnosis, prognosticators, and management of acute invasive fungal rhinosinusitis: multidisciplinary consensus statement and Evidence-Based review with recommendations.. Int Forum Allergy Rhinol.

Maoz SL, Wang EW, Hwang PH, Choby G, Kuan EC, Fleseriu CM, Chan EP, Adappa ND, Geltzeiler M, Getz AE et al..  2023.  Long-term quality of life after treatment in sinonasal malignancy: A prospective, multicenter study.. Int Forum Allergy Rhinol.

Fleseriu CM, Beswick DM, Maoz SL, Hwang PH, Choby G, Kuan EC, Chan EP, Adappa ND, Geltzeiler M, Getz AE et al..  2023.  Predictive factors for decreased baseline quality of life in patients with sinonasal malignancies.. Int Forum Allergy Rhinol.

Beswick DM, Hwang PH, Adappa ND, Le CH, DO IMHumphrey, Getz AE, Suh JD, Aasen DM, Abuzeid WM, Chang EH et al..  2021.  Surgical approach is associated with complication rate in sinonasal malignancy: A multicenter study.. Int Forum Allergy Rhinol. 11(12):1617-1625.